일회용 바이오리액터 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Single-use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1487520
리서치사:Transparency Market Research
발행일:2024년 04월
페이지 정보:영문 170 Pages
라이선스 & 가격 (부가세 별도)
한글목차
일회용 바이오리액터 시장 - 조사 범위
TMR의 일회용 바이오리액터 세계 시장 조사 보고서는 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측 연도로 하여 2018년부터 2034년까지 전 세계 일회용 바이오리액터 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 일회용 바이오리액터 시장의 연평균 복합 성장률(CAGR%)을 제시합니다.
이 보고서는 1차 조사에서 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 인터뷰하고, 2차 조사에서 주요 기업의 제품 자료, 연례 보고서, 언론 보도, 관련 문서를 참고하여 일회용 바이오리액터 시장을 이해하고자 했습니다. 보도자료, 관련 문서를 참고하였습니다.
시장 현황
2023년 시장 규모
21억 달러
2034년 시장 가치
67억 달러
CAGR
10.8%
이 보고서는 세계 일회용 바이오리액터 시장 경쟁 구도를 심층적으로 분석합니다. 세계 일회용 바이오리액터 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되어 있습니다. 기업 개요, 재무 상태, 최근 동향 및 SWOT는 이 보고서에서 다루는 세계 일회용 바이오리액터 시장의 기업 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
시장 개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19 팬데믹의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 제품 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 제품 유형별, 2020년-2034년
일회용 바이오리액터 시스템
미디어 백
여과 어셈블리
기타
시장의 매력 : 제품 유형별
제7장 세계 시장 분석과 예측 : 셀 타입별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 세포 유형별, 2020년-2034년
포유류 세포
세균 세포
효모 세포
기타
시장의 매력 : 세포 유형별
제8장 세계 시장 분석과 예측 : 분자 유형별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 분자 유형별, 2020년-2034년
단클론항체(MABs)
백신
줄기세포
유전자 변형 세포
기타
시장의 매력 : 분자 유형별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 매출 예측 : 최종사용자별, 2020-2034년
바이오의약품 기업
바이오테크놀러지 기업
기타
시장의 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 경쟁 매트릭스(기업 Tier별, 기업 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Danaher Corporation
General Electric Company
Merck KGaA
Sartorius AG
Thermo Fisher Scientific, Inc.
Eppendorf AG
Parker Hannifin Corporation
PBS Biotech, Inc.
Distek, Inc.
Getinge
LSH
영문 목차
영문목차
Single-Use Bioreactors Market - Scope of Report
TMR's report on the global single-use bioreactors market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global single-use bioreactors market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global single-use bioreactors market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the single-use bioreactors market.
Market Snapshot
Market Value in 2023
US$ 2.1 Bn
Market Value in 2034
US$ 6.7 Bn
CAGR
10.8%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global single-use bioreactors market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global single-use bioreactors market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global single-use bioreactors market.
The report delves into the competitive landscape of the global single-use bioreactors market. Key players operating in the global single-use bioreactors market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global single-use bioreactors market profiled in this report.
Key Questions Answered in Global single-use bioreactors Market Report:
What is the sales/revenue generated by single-use bioreactors across all regions during the forecast period?
What are the opportunities in the global single-use bioreactors market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Single-Use Bioreactors Market - Research Objectives and Research Approach
The comprehensive report on the global single-use bioreactors market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global single-use bioreactors market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global single-use bioreactors market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Single-use Bioreactors Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Single-use Bioreactors Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Single-use Bioreactors Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Single-use Bioreactor Systems
6.3.2. Media Bags
6.3.3. Filtration Assemblies
6.3.4. Others
6.4. Market Attractiveness, by Product Type
7. Global Single-use Bioreactors Market Analysis and Forecast, by Cell Type
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Cell Type, 2020-2034
7.3.1. Mammalian Cells
7.3.2. Bacterial Cells
7.3.3. Yeast Cells
7.3.4. Others
7.4. Market Attractiveness, by Cell Type
8. Global Single-use Bioreactors Market Analysis and Forecast, by Molecule Type
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Molecule Type, 2020-2034
8.3.1. Monoclonal Antibodies (MABs)
8.3.2. Vaccines
8.3.3. Stem Cells
8.3.4. Gene-modified Cells
8.3.5. Others
8.4. Market Attractiveness, by Molecule Type
9. Global Single-use Bioreactors Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Biopharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Others
9.4. Market Attractiveness, by End-user
10. Global Single-use Bioreactors Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Single-use Bioreactors Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Single-use Bioreactor Systems
11.2.2. Media Bags
11.2.3. Filtration Assemblies
11.2.4. Others
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Cell Type, 2020-2034
11.4.1. Mammalian Cells
11.4.2. Bacterial Cells
11.4.3. Yeast Cells
11.4.4. Others
11.5. Market Attractiveness, by Cell Type
11.6. Market Value Forecast, by Molecule Type, 2020-2034
11.6.1. Monoclonal Antibodies (MABs)
11.6.2. Vaccines
11.6.3. Stem Cells
11.6.4. Gene-modified Cells
11.6.5. Others
11.7. Market Attractiveness, by Molecule Type
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Biopharmaceutical Companies
11.8.2. Biotechnology Companies
11.8.3. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Cell Type
11.11.3. By Molecule Type
11.11.4. By End-user
11.11.5. By Country
12. Europe Single-use Bioreactors Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Single-use Bioreactor Systems
12.2.2. Media Bags
12.2.3. Filtration Assemblies
12.2.4. Others
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Cell Type, 2020-2034
12.4.1. Mammalian Cells
12.4.2. Bacterial Cells
12.4.3. Yeast Cells
12.4.4. Others
12.5. Market Attractiveness, by Cell Type
12.6. Market Value Forecast, by Molecule Type, 2020-2034
12.6.1. Monoclonal Antibodies (MABs)
12.6.2. Vaccines
12.6.3. Stem Cells
12.6.4. Gene-modified Cells
12.6.5. Others
12.7. Market Attractiveness, by Molecule Type
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Biopharmaceutical Companies
12.8.2. Biotechnology Companies
12.8.3. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Cell Type
12.11.3. By Molecule Type
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Single-use Bioreactors Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Single-use Bioreactor Systems
13.2.2. Media Bags
13.2.3. Filtration Assemblies
13.2.4. Others
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Cell Type, 2020-2034
13.4.1. Mammalian Cells
13.4.2. Bacterial Cells
13.4.3. Yeast Cells
13.4.4. Others
13.5. Market Attractiveness, by Cell Type
13.6. Market Value Forecast, by Molecule Type, 2020-2034
13.6.1. Monoclonal Antibodies (MABs)
13.6.2. Vaccines
13.6.3. Stem Cells
13.6.4. Gene-modified Cells
13.6.5. Others
13.7. Market Attractiveness, by Molecule Type
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Biopharmaceutical Companies
13.8.2. Biotechnology Companies
13.8.3. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Cell Type
13.11.3. By Molecule Type
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Single-use Bioreactors Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Single-use Bioreactor Systems
14.2.2. Media Bags
14.2.3. Filtration Assemblies
14.2.4. Others
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Cell Type, 2020-2034
14.4.1. Mammalian Cells
14.4.2. Bacterial Cells
14.4.3. Yeast Cells
14.4.4. Others
14.5. Market Attractiveness, by Cell Type
14.6. Market Value Forecast, by Molecule Type, 2020-2034
14.6.1. Monoclonal Antibodies (MABs)
14.6.2. Vaccines
14.6.3. Stem Cells
14.6.4. Gene-modified Cells
14.6.5. Others
14.7. Market Attractiveness, by Molecule Type
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Biopharmaceutical Companies
14.8.2. Biotechnology Companies
14.8.3. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Cell Type
14.11.3. By Molecule Type
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Single-use Bioreactors Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Single-use Bioreactor Systems
15.2.2. Media Bags
15.2.3. Filtration Assemblies
15.2.4. Others
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Cell Type, 2020-2034
15.4.1. Mammalian Cells
15.4.2. Bacterial Cells
15.4.3. Yeast Cells
15.4.4. Others
15.5. Market Attractiveness, by Cell Type
15.6. Market Value Forecast, by Molecule Type, 2020-2034
15.6.1. Monoclonal Antibodies (MABs)
15.6.2. Vaccines
15.6.3. Stem Cells
15.6.4. Gene-modified Cells
15.6.5. Others
15.7. Market Attractiveness, by Molecule Type
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Biopharmaceutical Companies
15.8.2. Biotechnology Companies
15.8.3. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Cell Type
15.11.3. By Molecule Type
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Danaher Corporation
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. General Electric Company
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Merck KGaA
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Sartorius AG
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Thermo Fisher Scientific, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Eppendorf AG
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Parker Hannifin Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. PBS Biotech, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Distek, Inc.
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Getinge
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
